Clinical Trials Browser

Phase 1 × trifluridine tipiracil drug combination × 30 days × Clear all

NCT04511039 2026-03-02

Trifluridine/Tipiracil and Talazoparib for the Treatment of Patients With Locally Advanced or Metastatic Colorectal or Gastroesophageal Cancer

Phase 1 Recruiting

Gastrointestinal

Colorectal Neoplasms